Found 138 matching trials
High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer
PHASE3RATIONALE: Radioactive iodine uses radiation to kill tumor cells. Giving io...
Location
Sussex Cancer Centre at Royal Sussex County Hospital
Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine
PHASE2This phase II trial is studying how well romidepsin works in treating patie...
Location
Memorial Sloan-Kettering Cancer Center at Suffolk
Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer
PHASE2RATIONALE: Drugs such as valproic acid may make thyroid cancers more radioi...
Location
UCSF Comprehensive Cancer Center
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
PHASE2This phase II trial studies how well cabozantinib-s-malate works in treatin...
Location
MedStar Georgetown University Hospital
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer
PHASE2This phase II trial studies how well encorafenib and binimetinib given with...
Status
Active Not Recruiting
Location
Providence Portland Medical Center
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
PHASE2This research is being done to determine the efficacy of selpercatinib to r...
Location
MedStar Washington Hospital Center
Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
N/AThe aim of this study was to assess the impact of adjuvant radioactive iodi...
Location
Zhujiang Hospital,Southern Medical University
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
PHASE2The purpose of this study is to find out whether a drug called PDR001, comb...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Antithyroid Drugs During Radioiodine Therapy
PHASE4Background: The use of radioactive iodine (131I) therapy as the definite cu...
Location
Department of Endocrinology, Odense University Hospital
Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer
NAThis study aims to observe and explore the efficacy and safety of Anlotinib...